Posted on January 15, 2014 by Sitemaster
It has been brought to our attention by one of our readers that a Swedish company called AroCell is developing a new test that may have potential in monitoring for risk of prostate cancer progression. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: biomarker, kinase, progression, risk, thymidine | 11 Comments »
Posted on November 22, 2011 by Sitemaster
An article published on line in the Journal of Urology last Friday suggests that an enzyme known as G-protein-coupled receptor kinase 5 or GRK5 may have an important role in the regulation of the growth of prostate cancer. … READ MORE …
Filed under: Drugs in development | Tagged: G-protein, GRK5, kinase, receptor | Leave a comment »
Posted on September 12, 2011 by Sitemaster
Oncothyreon, Inc. has announced initiation of a Phase II clinical trial of the company’s investigational agent PX-866 in the treatment of men with chemotherapy-naïve, recurrent or metastatic, castration-resistant prostate cancer (CRPC). … READ MORE …
Filed under: Drugs in development, Management | Tagged: castration-resistant, inhibitor, kinase, metastatic, Oncothyreon, PX-866 | Leave a comment »
